VR Adviser, LLC Diversified Active

CIK: 0001615982 · Show all filings

Period: Q1 2020 (Next →)

Filing Date: May 15, 2020

Total Value ($000): $369,181 (100.0% shares, 0.0% debt)

Holdings (16)

— CONSTELLATION PHARMACEUTICALS INC 34.2%

Value ($000) $126,250 Shares 4,016,873 Est. Cost $31.43 Unrealized —

AXSM AXSOME THERAPEUTICS INC 12.9%

Value ($000) $47,652 Shares 810,000 Est. Cost $81.48 Unrealized 0.0%

RLMD RELMADA THERAPEUTICS INC 7.8%

Value ($000) $28,748 Shares 842,814 Est. Cost $40.32 Unrealized 0.0%

— TRILLIUM THERAPEUTICS INC 7.4%

Value ($000) $27,432 Shares 6,790,000 Est. Cost $4.04 Unrealized —

— 89BIO INC 6.5%

Value ($000) $24,043 Shares 952,200 Est. Cost $25.25 Unrealized —

— INOVIO PHARMACEUTICALS INC 5.8%

Value ($000) $21,576 Shares 2,900,000 Est. Cost $7.44 Unrealized —

TXG 10X GENOMICS INC 5.1%

Value ($000) $18,696 Shares 300,000 Est. Cost $78.04 Unrealized 0.0%

— MERSANA THERAPEUTICS INC 4.1%

Value ($000) $15,297 Shares 2,623,903 Est. Cost $5.83 Unrealized —

— MARINUS PHARMACEUTICALS INC 3.6%

Value ($000) $13,201 Shares 6,502,840 Est. Cost $2.03 Unrealized —

— VERASTEM INC 2.7%

Value ($000) $9,823 Shares 3,720,930 Est. Cost $2.64 Unrealized —

— ADVERUM BIOTECHNOLOGIES INC 2.6%

Value ($000) $9,715 Shares 994,381 Est. Cost $9.77 Unrealized —

— IVERIC BIO INC 2.4%

Value ($000) $8,898 Shares 2,586,537 Est. Cost $3.44 Unrealized —

— AVADEL PHARMACEUTICALS PLC 2.3%

Value ($000) $8,399 Shares 1,057,827 Est. Cost $7.94 Unrealized —

— SIERRA ONCOLOGY INC 1.3%

Value ($000) $4,822 Shares 491,017 Est. Cost $9.82 Unrealized —

SPRO SPERO THERAPEUTICS INC 1.0%

Value ($000) $3,830 Shares 474,015 Est. Cost $8.81 Unrealized 0.0%

PTGX PROTAGONIST THERAPEUTICS INC 0.2%

Value ($000) $799 Shares 113,140 Est. Cost $7.49 Unrealized 0.0%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	CONSTELLATION PHARMACEUTICALS INC	4,016,873	$126,250	34.2%	$31.43	—	COM	210373106
AXSM	AXSOME THERAPEUTICS INC	810,000	$47,652	12.9%	$81.48	0.0%	COM	05464T104
RLMD	RELMADA THERAPEUTICS INC	842,814	$28,748	7.8%	$40.32	0.0%	COM	75955J402
—	TRILLIUM THERAPEUTICS INC	6,790,000	$27,432	7.4%	$4.04	—	COM NEW	89620X506
—	89BIO INC	952,200	$24,043	6.5%	$25.25	—	COM	282559103
—	INOVIO PHARMACEUTICALS INC	2,900,000	$21,576	5.8%	$7.44	—	COM NEW	45773H201
TXG	10X GENOMICS INC	300,000	$18,696	5.1%	$78.04	0.0%	CL A COM	88025U109
—	MERSANA THERAPEUTICS INC	2,623,903	$15,297	4.1%	$5.83	—	COM	59045L106
—	MARINUS PHARMACEUTICALS INC	6,502,840	$13,201	3.6%	$2.03	—	COM	56854Q101
—	VERASTEM INC	3,720,930	$9,823	2.7%	$2.64	—	COM	92337C104
—	ADVERUM BIOTECHNOLOGIES INC	994,381	$9,715	2.6%	$9.77	—	COM	00773U108
—	IVERIC BIO INC	2,586,537	$8,898	2.4%	$3.44	—	COM	46583P102
—	AVADEL PHARMACEUTICALS PLC	1,057,827	$8,399	2.3%	$7.94	—	SPONS ADR	05337M104
—	SIERRA ONCOLOGY INC	491,017	$4,822	1.3%	$9.82	—	COM NEW	82640U404
SPRO	SPERO THERAPEUTICS INC	474,015	$3,830	1.0%	$8.81	0.0%	COM	84833T103
PTGX	PROTAGONIST THERAPEUTICS INC	113,140	$799	0.2%	$7.49	0.0%	COM	74366E102